Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME Part II: Albumin Strategy in Cardiac Surgery
NCT05647200Unknown
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2023
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of albumin (human) in Microcirculatory dysfunction (MVD) and endothelial dysfunction (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Perfused vessel density. Status: unknown.
02
Drugs
albumin (human)
03
Conditions
Microcirculatory dysfunction (MVD)endothelial dysfunction
Beyond the preview
Go deeper on NCT05647200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05647200.